Morgan EL - Search Results

1

Control of methicillin resistant Staphylococcus aureus infection utilizing a novel immunostimulatory peptide.

Sheen TR, Cavaco CK, Ebrahimi CM, Thoman ML, Sanderson SD, Morgan EL, Doran KS. Sheen TR, et al. Among authors: morgan el. Vaccine. 2011 Dec 9;30(1):9-13. doi: 10.1016/j.vaccine.2011.10.054. Epub 2011 Oct 30. Vaccine. 2011. PMID: 22044742 Free PMC article.

2

Enhancement of in vivo and in vitro immune functions by a conformationally biased, response-selective agonist of human C5a: implications for a novel adjuvant in vaccine design.

Morgan EL, Morgan BN, Stein EA, Vitrs EL, Thoman ML, Sanderson SD, Phillips JA. Morgan EL, et al. Among authors: morgan bn. Vaccine. 2009 Dec 11;28(2):463-9. doi: 10.1016/j.vaccine.2009.10.029. Epub 2009 Oct 15. Vaccine. 2009. PMID: 19836478 Free PMC article.

3

A novel adjuvant for vaccine development in the aged.

Morgan EL, Thoman ML, Sanderson SD, Phillips JA. Morgan EL, et al. Vaccine. 2010 Dec 6;28(52):8275-9. doi: 10.1016/j.vaccine.2010.10.008. Epub 2010 Oct 19. Vaccine. 2010. PMID: 20965299 Free PMC article.

4

An agonist of human complement fragment C5a enhances vaccine immunity against Coccidioides infection.

Hung CY, Hurtgen BJ, Bellecourt M, Sanderson SD, Morgan EL, Cole GT. Hung CY, et al. Among authors: morgan el. Vaccine. 2012 Jun 29;30(31):4681-90. doi: 10.1016/j.vaccine.2012.04.084. Epub 2012 May 8. Vaccine. 2012. PMID: 22575167 Free PMC article.

5

A novel C5a-derived immunobiotic peptide reduces Streptococcus agalactiae colonization through targeted bacterial killing.

Cavaco CK, Patras KA, Zlamal JE, Thoman ML, Morgan EL, Sanderson SD, Doran KS. Cavaco CK, et al. Among authors: morgan el. Antimicrob Agents Chemother. 2013 Nov;57(11):5492-9. doi: 10.1128/AAC.01590-13. Epub 2013 Aug 26. Antimicrob Agents Chemother. 2013. PMID: 23979760 Free PMC article.

6

Single-step conjugation of bioactive peptides to proteins via a self-contained succinimidyl bis-arylhydrazone.

Phillips JA, Morgan EL, Dong Y, Cole GT, McMahan C, Hung CY, Sanderson SD. Phillips JA, et al. Among authors: morgan el. Bioconjug Chem. 2009 Oct 21;20(10):1950-7. doi: 10.1021/bc9002794. Epub 2009 Sep 29. Bioconjug Chem. 2009. PMID: 19788175 Free PMC article.

7

Anti-human kappa opioid receptor antibodies: characterization of site-directed neutralizing antibodies specific for a peptide kappa R(33-52) derived from the predicted amino terminal region of the human kappa receptor.

Buchner RR, Vogen SM, Fischer W, Thoman ML, Sanderson SD, Morgan EL. Buchner RR, et al. Among authors: morgan el. J Immunol. 1997 Feb 15;158(4):1670-80. J Immunol. 1997. PMID: 9029103

8

Induction of interleukin-8 synthesis from monocytes by human C5a anaphylatoxin.

Ember JA, Sanderson SD, Hugli TE, Morgan EL. Ember JA, et al. Among authors: morgan el. Am J Pathol. 1994 Feb;144(2):393-403. Am J Pathol. 1994. PMID: 7508686 Free PMC article.

9

Anti-C5a receptor antibodies. Characterization of neutralizing antibodies specific for a peptide, C5aR-(9-29), derived from the predicted amino-terminal sequence of the human C5a receptor.

Morgan EL, Ember JA, Sanderson SD, Scholz W, Buchner R, Ye RD, Hugli TE. Morgan EL, et al. J Immunol. 1993 Jul 1;151(1):377-88. J Immunol. 1993. PMID: 8326131

10

Induction of human B cell differentiation by Fc region activators. II. Stimulation of IL-6 production.

Morgan EL, Hobbs MV, Thoman ML, Janda J, Noonan DJ, Kadar J, Weigle WO. Morgan EL, et al. J Immunol. 1990 Apr 1;144(7):2499-505. J Immunol. 1990. PMID: 2319130

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

133 results

Search Page

Filters